Literature DB >> 16575722

Emerging chloroquine-resistant Plasmodium vivax (Benign Tertian) malaria: the need for alternative drug treatment.

Joseph M Vinetz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16575722     DOI： 10.1086/501353

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Whole-genome sequencing and microarray analysis of ex vivo Plasmodium vivax reveal selective pressure on putative drug resistance genes.

Authors:  Neekesh V Dharia; A Taylor Bright; Scott J Westenberger; S Whitney Barnes; Serge Batalov; Kelli Kuhen; Rachel Borboa; Glenn C Federe; Colleen M McClean; Joseph M Vinetz; Victor Neyra; Alejandro Llanos-Cuentas; John W Barnwell; John R Walker; Elizabeth A Winzeler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-29       Impact factor: 11.205

2.  Malaria in the UK: new prevention guidelines for UK travellers.

Authors:  Barbara Bannister
Journal:  Br J Gen Pract       Date:  2007-01       Impact factor: 5.386

3.  Improved assessment of plasmodium vivax response to antimalarial drugs by a colorimetric double-site plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay.

Authors:  Pierre Druilhe; Philippe Brasseur; Catherine Blanc; Michael Makler
Journal:  Antimicrob Agents Chemother       Date:  2007-03-26       Impact factor: 5.191

4.  MOLECULAR SURVEILLANCE OF Plasmodium vivax AND Plasmodium falciparum DHFR MUTATIONS IN ISOLATES FROM SOUTHERN IRAN.

Authors:  Khojasteh Sharifi-Sarasiabi; Ali Haghighi; Bahram Kazemi; Niloofar Taghipour; Ehsan Nazemalhosseini Mojarad; Latif Gachkar
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-03-22       Impact factor: 1.846
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.